Centaur Biopharmaceutical Services Inc., a wholly-owned subsidiary of Kindred Biosciences Inc., has announced an expanded agreement between KindredBio and Vaxart Inc. under which Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.   Centaur is a full-service contract development and manufacturing organization that specializes in protein-based biologics and virus-based products. With facilities in California and Kansas, Centaur’s capabilities span...